Home LiteratureArticle Details
PMID: 9419970 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet.

Oncogene ·Vol. 15 ·No. 23 ·1997-12-04 ·Pages 2795-801

Hu JF, Cheng Z, Chisari FV, Vu TH, Hoffman AR, Campbell TC

Abstract

Persistent infection with hepatitis B virus (HBV) is one of the primary risk factors for human hepatocellular carcinoma (HCC). In a human ecological study, we have shown that, in addition to HBV, animal food consumption also significantly contributes to the variance of HCC. To test the interacting effect of HBV and animal food consumption on the development of HCC, we investigated HBV expression in HBV transgenic mice fed three levels of casein diet. HBV expression in transgenic animals was substantially inhibited when dietary casein was reduced from the traditional level of 22% to the level of 6%. Northern analysis revealed that suppression of HBV was derived from both the upstream albumin promoter and the internal HBV promoter. Immunochemical staining of liver sections indicated that only a few hepatocytes around the central vein expressed viral surface antigen (HBsAg) in the 6% casein animals, whereas virtually all hepatocytes stained positively for HBsAg in the 22% dietary casein animals. Serum HBsAg concentrations at 4 months were increased by 1.6-, 2.1-, and 5.1- fold over baseline for animals fed the 6%, 14%, and 22% casein diets, respectively. Correspondingly, liver injury was much less severe in animals fed 6% casein diet than in those fed 14% and 22% casein diets. These results demonstrate that a low casein diet is a potent suppresser of HBV transgene and HBV-induced liver injury, suggesting that diet management may be a practical means to aid in the control HBV infection.

MeSH Terms
Animals Caseins/administration & dosage Female Gene Expression Regulation/drug effects Genes, Viral/drug effects Hepatitis B/diet therapy,pathology,virology Hepatitis B virus/drug effects,genetics Hepatocyte Growth Factor/biosynthesis,genetics Insulin-Like Growth Factor I/biosynthesis,genetics Male Mice Mice, Inbred C3H Mice, Transgenic Transgenes/drug effects Viral Structural Proteins/genetics
Chemicals
Caseins Viral Structural Proteins Hepatocyte Growth Factor Insulin-Like Growth Factor I
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hu J F
VA Medical Center, Department of Medicine, Stanford University, Palo Alto, California 94304, USA.
Cheng Z
Chisari F V
Vu T H
Hoffman A R
Campbell T C
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
1997-12-04
Pages
2795-801
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · R01-CA34205 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]